Clinical Trial Update: Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating immunotherapy without chemotherapy for advanced non-small cell lung cancer with high PD-L1 expression; the study is currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: UNICANCER | Conditions: Non Small Cell Lung Cancer (Squamous or Non Squamous) | Phase 2 | Status: NOT_YET_RECRUITING